- Home
- LDWY vs BDRX Comparison
LDWY vs BDRX Comparison
Compare LDWY & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDWY
- BDRX
- Stock Information
- Founded
- LDWY 1990
- BDRX 2000
- Country
- LDWY United States
- BDRX United Kingdom
- Employees
- LDWY N/A
- BDRX N/A
- Industry
- LDWY Advertising
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- LDWY Consumer Discretionary
- BDRX Health Care
- Exchange
- LDWY Nasdaq
- BDRX Nasdaq
- Market Cap
- LDWY 8.9M
- BDRX 3.9M
- IPO Year
- LDWY 1991
- BDRX N/A
- Fundamental
- Price
- LDWY $4.69
- BDRX $7.18
- Analyst Decision
- LDWY
- BDRX
- Analyst Count
- LDWY 0
- BDRX 0
- Target Price
- LDWY N/A
- BDRX N/A
- AVG Volume (30 Days)
- LDWY 1.5K
- BDRX 350.6K
- Earning Date
- LDWY 11-18-2025
- BDRX 09-12-2025
- Dividend Yield
- LDWY N/A
- BDRX N/A
- EPS Growth
- LDWY N/A
- BDRX N/A
- EPS
- LDWY 1.66
- BDRX N/A
- Revenue
- LDWY $71,244,000.00
- BDRX N/A
- Revenue This Year
- LDWY N/A
- BDRX N/A
- Revenue Next Year
- LDWY N/A
- BDRX N/A
- P/E Ratio
- LDWY $2.90
- BDRX N/A
- Revenue Growth
- LDWY 187.12
- BDRX N/A
- 52 Week Low
- LDWY $3.23
- BDRX $5.00
- 52 Week High
- LDWY $6.19
- BDRX $92.00
- Technical
- Relative Strength Index (RSI)
- LDWY 40.60
- BDRX 49.20
- Support Level
- LDWY $4.63
- BDRX $6.60
- Resistance Level
- LDWY $5.04
- BDRX $7.71
- Average True Range (ATR)
- LDWY 0.18
- BDRX 1.00
- MACD
- LDWY -0.04
- BDRX -0.21
- Stochastic Oscillator
- LDWY 6.19
- BDRX 15.40
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two industries: Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.